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RORgt+ innate lymphoid cells (ILCs) are crucial
players of innate immune responses and represent
a major source of interleukin-22 (IL-22), which has
an important role in mucosal homeostasis. The sig-
nals required by RORgt+ ILCs to express IL-22 and
other cytokines have been elucidated only partially.
Here we showed that RORgt+ ILCs can directly sense
the environment by the engagement of the activating
receptor NKp44. NKp44 triggering in RORgt+ ILCs
selectively activated a coordinated proinflammatory
program, including tumor necrosis factor (TNF),
whereas cytokine stimulation preferentially induced
IL-22 expression. However, combined engagement
of NKp44 and cytokine receptors resulted in a strong
synergistic effect. These data support the concept
that NKp44+ RORgt+ ILCs can be activated without
cytokines and are able to switch between IL-22 or
TNFproduction,dependingon the triggeringstimulus.
INTRODUCTION
Innate lymphoid cells (ILCs) comprise different lymphocyte pop-
ulations sharing developmental requirements, such as depen-
dence on the transcription factor inhibitor of DNA binding 2
(Id2) and g-chain cytokines. In addition to conventional natural
killer (cNK) cells and natural helper cells (ILC2), ILCs comprisea population of cells expressing CD127 (IL7Ra) and the orphan
nuclear receptor RORgt, referred to as RORgt+ ILCs. RORgt+
ILCs include fetal lymphoid tissue-inducer (LTi) and adult LTi-
like cells (Spits and Cupedo, 2012), which can be found after
birth in secondary lymphoid organs or at mucosal sites (Cupedo
et al., 2009; Mebius et al., 1997) and represent a major source of
interleukin-22 (IL-22) (Cella et al., 2009; Cupedo et al., 2009; Luci
et al., 2009; Sanos et al., 2009; Satoh-Takayama et al., 2008;
Takatori et al., 2009). Expression of IL-22 by non-T cells is pro-
tective in inflammatory bowel disease (IBD) (Zenewicz et al.,
2008), suggesting that IL-22 producing ILCs might modulate in-
testinal inflammation. IL-22 mediates these effects via its role in
host defense against bacterial infection,mucosal wound healing,
and intestinal epithelial cell homeostasis (Ouyang et al., 2011).
Besides IL-22, RORgt+ ILCs produce several other cytokines
including granulocyte macrophage colony-stimulating factor
(GM-CSF), IL-13, IL-2, tumor necrosis factor (TNF), IL-17A and
interferon-g (IFN-g) (Spits and Cupedo, 2012). Indeed, a
potential pathogenic role of RORgt+ ILCs in experimental colitis
models has also been shown in some reports (Buonocore et al.,
2010; Geremia et al., 2011; Vonarbourg et al., 2010). The basis
for the potential dual role of RORgt+ ILCs is poorly understood
but certainly of major importance. RORgt+ ILCs might include
distinct cell subsets characterized by different cytokine profiles
and functional properties. In adult mice, two main subsets of
RORgt+ ILCs are defined according to the expression of
NKp46 (Luci et al., 2009; Sanos et al., 2009; Satoh-Takayama
et al., 2008). In adult humans, RORgt+ ILCs can be dissected
according to the expression of CD56 (Cupedo et al., 2009) or
NKp44 (Cella et al., 2009). This heterogeneity might contribute
to explain the distinct roles of RORgt+ ILCs in disease settings.Immunity 38, 1223–1235, June 27, 2013 ª2013 Elsevier Inc. 1223
Figure 1. IL-22 but Not TNF Expression Is Confined to NKp44+ RORgt+ ILCs
Analysis of phenotype and cytokine profile of human tonsil-derived RORgt+ ILC subsets.
(A) Expression of CD127 and CD56 on viable (LD) CD3 CD14 CD19 mononuclear cells (MNC) was analyzed by flow cytometry (FC) (left). RORC and AHR
mRNA was detected by quantitative RT-PCR (qPCR) in FACS-sorted CD56+ CD127hi Lin (CD3 CD14 CD19 CD94) cells (‘‘CD56+,’’ red), CD56 CD127hi
Lin cells (‘‘CD56,’’ blue) and CD56+ CD127lo/neg CD3 CD14 CD19 CD94+ cNK cells (right). Mean fold change ± SEM relative to cNK cells is plotted (n = 3),
after normalizing to GAPDH.
(B) Expression of NKp44 was analyzed by FC after gating on CD56+ CD127hi Lin (red line), CD56 CD127hi Lin (blue line), cNK cells (black line), or CD56
CD127 Lin cells (ctr, solid gray histograms), as control. One representative experiment (left) and mean percentage ± SEM (right) are shown (n = 6).
(C) Sorting strategy of CD127hi cells according to the expression of NKp44 and CD56, after gating on Lin MNC.
(legend continued on next page)
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NKp44 Triggering Activates RORgt+ ILCsAlternatively, it is possible that RORgt+ ILCs can acquire different
effector functions depending on the activation context. IL-22
production by RORgt+ ILCs mainly depends on IL-23 and IL-1
released by antigen presenting cells (APCs) (Spits and Cupedo,
2012). However, RORgt+ ILCs might also directly sense the envi-
ronment by the expression of aryl hydrocarbon receptor (AHR)
(Kiss et al., 2011; Lee et al., 2012) or Toll-like receptor 2 (TLR2)
(Crellin et al., 2010). Because TLR2 agonists induce IL-22 and/
or IL-13 and IL-5 production only in the presence of IL-23 or
IL-2 (Crellin et al., 2010), it still remains unclear whether RORgt+
ILCs can be activated completely independent of cytokines.
Moreover, signals driving RORgt+ ILC expression of proinflam-
matory cytokines, such as TNF, need to be identified. In addition
to cytokine receptors, innate cells employ RAG-independent
strategies to sense pathogen-associated molecular patterns or
danger signals induced in infected or transformed cells. For
instance, cNK cells express several activating receptors (NKR),
such as NKp46, NKp44, and NKp30. Although these three Ig-like
receptors are all present in the human genome, only NKp46 dis-
plays high homology in mice. NKR engagement elicits cytokine
release and degranulation of cytotoxic effector molecules in
cNK cells. Although the nature of many NKR ligands remains
elusive, their expression can be induced in infected or trans-
formed cells (Moretta et al., 2001). Influenza virus (IV) hemagglu-
tinin (HA) was shown to bind to NKp46 and NKp44; moreover,
NKp46-deficient mice display increased susceptibility to lethal
IV infection (Arnon et al., 2001; Gazit et al., 2006; Mandelboim
et al., 2001). RORgt+ ILCs also express NKR. Although cross-
linking of NKp46 or NK1.1 does not seem to elicit cytokine
expression in RORgt+ ILCs derived from mouse small intestine
(SI) (Satoh-Takayama et al., 2009), further analysis is required
to clarify whether NKR engagement can trigger effector func-
tions in different RORgt+ ILC subsets.
Here, we analyzed the signal requirements for cytokine
expression in humanRORgt+ ILCs and showed that engagement
of the activating receptor NKp44 is sufficient to trigger selec-
tive TNF production and inflammatory gene signatures, while
cytokine stimulation preferentially drives IL-22 expression in
RORgt+ ILCs.
RESULTS
IL-22 but Not TNF Expression Is Confined to NKp44+
RORgt+ ILCs
Human RORgt+ ILCs can be identified as CD127hi Lin cells
(Cupedo et al., 2009) and dissected in different subsets accord-
ing to the expression of CD56 and NKp44 (Cella et al., 2009;
Cupedo et al., 2009). In order to assess the heterogeneity of
tonsil RORgt+ ILCs, their ex vivo phenotype and functions were
analyzed. Tonsil-derived CD56+ and CD56 RORgt+ ILCs dis-
played comparable expression of RORC and AHR (Figure 1A),
as well as CD117, CCR6, CD161, lymphotoxin a1b2 (as shown(D) RORC and AHR mRNA in the four CD127hi Lin subsets sorted as in (C) was
(E) Expression of indicated markers analyzed by FC on the following populations:
dotted line), NKp44+ CD56 CD127hi Lin (blue solid line), NKp44 CD56 CD1
histograms). One representative experiment out of three is shown.
(F and G) CD127hi Lin cells were FACS sorted as described in (C) and intracellul
with PMA+Ionomycin (Iono)+IL-23. One representative experiment (F) and meanby staining with LTbR-Fc), and receptor activator of NF-kB
ligand (RANKL) (see Figure S1A available online). Conversely,
both RORgt+ ILC subsets neither expressed the ILC2 marker
CRTH2 (Mjo¨sberg et al., 2011), nor the cNK cell markers CD94
and T-box transcription factors T-bet and eomesodermin
(Eomes) (Figure S1A). CD56+ and CD56RORgt+ ILCs displayed
also similar cytokine profiles, although percentage of producing
cells was lower among CD56 RORgt+ ILCs (Figure S1B).
IFN-g, IL-17A, IL-13 (Figure S1B), and IL-5 (data not shown)
were almost undetectable after intracellular staining, whereas
both subsets produced IL-22, GM-CSF, IL-2, and TNF (Fig-
ure S1B). TNF protein could be detected not only intracellular,
but also on the membrane (Figure S1C). Because expression of
NKp44 was clearly bimodal with the CD56+ compartment being
higher enriched inNKp44+ cells compared to theCD56 counter-
part (Figure 1B), we investigated phenotype and cytokine profile
of CD127hi Lin ILC subsets sorted according to NKp44 and
CD56 expression (Figure 1C). Although NKp44 and NKp44+
cells displayed comparable RORC and AHR transcripts (Fig-
ure 1D) and exhibited a similar surface phenotype (Figure 1E),
IL-22 production was exclusively confined to the NKp44+ com-
partments, especially to the CD56+ NKp44+ one, whereas GM-
CSF was significantly higher expressed among NKp44 cells.
No differences in TNF production could be observed among the
different subsets (Figures 1F and 1G). These data show that,
although both NKp44 and NKp44+ CD127hi Lin cells likely
represent RORgt+ ILCs and display a comparable phenotype,
expressionof IL-22 is a specifichallmarkofNKp44+RORgt+ ILCs.
NKp44 Is Functional in RORgt+ ILCs and Its Engagement
Induces Selective TNF Expression
RORgt+ ILCs were then analyzed for their expression and func-
tionality of NK cell-activating receptors. In addition to NKp44,
most RORgt+ ILCs expressed NKp30 and NKp46 (Figure 2A).
Interestingly, only engagement of NKp44, but not of NKp30,
NKp46, NKG2D (Figures 2B and 2C), CD161, or CD2 alone (Fig-
ure S2A) was able to elicit cytokine expression, namely TNF and
few IL-2, in RORgt+ ILCs (Figures 2B–2D). The effects of com-
bined engagement of NKp44 with NKp46 and NKp30 were
similar to stimulation via NKp44 alone (Figure S2B). Conversely,
almost no IL-22 or GM-CSF expression could be detected after
NKp44 engagement (Figure 2D). Cytokine expression detected
in RORgt+ ILCs by intracellular staining was also confirmed by
measuring messenger RNA (mRNA) content and secreted pro-
tein at different time points after aNKp44 triggering (Figure S2C).
Triggering of NKp44 resulted in cytokine expression only in
NKp44+ but not in NKp44 RORgt+ ILCs (Figure 2E), whereas
no major differences could be observed comparing CD56+ and
CD56 RORgt+ ILCs (data not shown). Specificity of NKp44
engagement on RORgt+ ILCs was confirmed by the strong
reduction of cytokine production in the presence of a different
aNKp44 blocking monoclonal antibody (mAb), but not in themeasured and shown as described in (A) (n = 3).
NKp44+ CD56+ CD127hi Lin (red solid line), NKp44 CD56+ CD127hi Lin (red
27hi Lin (blue dotted line), cNK cells (black solid line), or ctr cells (solid gray
ar expression of the indicated cytokines was measured by FC after stimulation
percentage ± SEM (G) are plotted (n = 6). See also Figure S1.
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Figure 2. NKp44 Is Functional in RORgt+ ILCs and Its Engagement Induces Selective TNF Expression
Ex vivo analysis of cytokine profile of FACS-sorted RORgt+ ILCs derived from human tonsil after stimulation via different NKR.
(A) Surface expression of the indicated NKRwasmeasured by FC after gating on different Lin subsets, as described in Figure 1E. One representative experiment
out of three is shown.
(B–D) Intracellular cytokine expression was analyzed by FC on FACS-sorted CD56+ CD127hi Lin cells stimulated as indicated (B and C) or with cross-linking of
NKp44 (aNKp44) only (D). One representative experiment (B and D, left) and mean percentage ± SEM (C and D, right) are shown (n = 6).
(E) FACS-sorted NKp44+ (white bars) and NKp44 (black bars) CD56+ CD127hi Lin cells were stimulated with aNKp44, and mean percentage ± SEM of cytokine
producing cells is shown (n = 6).
(F) FACS-sorted CD56+ CD127hi Lin cells were stimulated with aNKp44 in the presence or absence of aNKp44-blocking (NKp44 block) or isotype control-
blocking (ctr block) mAb. Intracellular expression of TNF was measured by FC, and mean percentage ± SEM of TNF+ cells is shown (n = 3).
(G) Expression of NKp44 was analyzed by FC on the murine thymoma BW reporter cells being either untransfected (BW, black dotted line) or transfected with
NKp44–CD3z chimera (BW-NKp44, black solid line). Isotype controls are shown for BW cells (gray dotted line) and BW-NKp44 (gray solid line), respectively. One
representative experiment out of three is shown.
(H) Stimulation of BW or BW-NKp44 reporter cells with the indicated stimuli. Expression of murine IL-2 by BW cells was measured by ELISA and plotted as mean
absorbance (O.D. 450 nm) of duplicates from one representative experiment out of three. See also Figures S1 and S2.
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NKp44 Triggering Activates RORgt+ ILCspresence of isotype control mAb (Figure 2F); moreover, aNKp44
selectively activated the mouse BW cell line transfected with a
construct encoding human NKp44-CD3z-chain chimeric protein
(BW-NKp44), thus displaying high surface expression of the
NKp44 extracellular portion (Figure 2G), but not untransfected
BW cells (Figure 2H). BW-NKp44 activation could be abolished
by addition of aNKp44 blocking mAb (Figure 2H). These data1226 Immunity 38, 1223–1235, June 27, 2013 ª2013 Elsevier Inc.show that engagement of NKp44 is sufficient to induce TNF,
but not IL-22 expression, in RORgt+ ILCs.
Cytokines Preferentially Induce IL-22 Production in
RORgt+ ILCs
Human RORgt+ ILCs can respond to several cytokines, such as
IL-23, IL-1, IL-7, and IL-15, resulting in IL-22 production and/or
Figure 3. Cytokines Preferentially Induce IL-22 Production in RORgt+ ILCs
Ex vivo analysis of cytokine profile of FACS-sorted RORgt+ ILCs derived from human tonsil after stimulation with different cytokine combinations.
(A) Surface expression of IL-1R1 and IL-23R was measured by FC after gating as described in Figure 1E. One representative experiment out of three is shown.
(B) Intracellular expression of phosphorylated (p-) NF-kB, STAT3, and STAT5 was analyzed by FC in FACS-sorted CD56+ CD127hi Lin cells either unstimulated
(dotted line) or stimulated (solid line) for 15minwith the indicated cytokines. One representative experiment out of three is shown. Geometrical mean fluorescence
intensity (MFI) ± SEM (n = 3) of unstimulated (italic numbers) or stimulated cells (bold numbers) is indicated in each plot.
(C–E) FACS-sorted CD56+ CD127hi Lin cells were stimulated as indicated (C and D) or with IL-1+IL-7+IL-23 (E) and intracellular cytokine expression was
measured by FC. One representative experiment (C) and (E, left) and mean percentage ± SEM of cytokine producing cells (D) and (E, right) are shown (n = 6).
(F) FACS-sorted NKp44+ (white bars) and NKp44 (black bars) CD56+ CD127hi Lin cells were stimulated with IL-1+IL-7+IL-23 and cytokine expression was
measured by FC. Mean percentage ± SEM of cytokine-producing cells is shown (n = 6). See also Figure S2.
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NKp44 Triggering Activates RORgt+ ILCsproliferation (Cella et al., 2010; Crellin et al., 2010). Cytokine
receptors for IL-7 (Figure 1A), IL-1, and IL-23 (Figure 3A) were
highly expressed ex vivo on all RORgt+ ILC compartments and
were functional because short stimulation with IL-1, IL-7, IL-23,or their combination promptly induced NF-kB, STAT5, and
STAT3 phosphorylation, respectively (Figure 3B). Even though
functional cytokine receptors were expressed, none of the above
mentioned cytokines induced IL-22 expression in RORgt+ ILCsImmunity 38, 1223–1235, June 27, 2013 ª2013 Elsevier Inc. 1227
Figure 4. NKp44 Engagement Acts Synergistically with Cytokine
Stimulation to Induce IL-22, GM-CSF, IL-2, and TNF
Ex vivo analysis of cytokine profile of human tonsil-derived FACS-sorted
RORgt+ ILCs after stimulation with different combinations of aNKp44 and
cytokines.
(A–C) Intracellular cytokine expression of FACS-sorted CD56+ CD127hi Lin
cells stimulated as indicated was measured by FC. One representative
experiment (A) and mean percentage ± SEM (B and C) of cytokine producing
cells are shown (n = 6).
(D) Intracellular cytokine expression of FACS-sorted NKp44+ (top) andNKp44
(bottom) CD56+ CD127hi Lin cells stimulated as indicated is depicted as
mean percentage ± SEM of cytokine-producing cells (n = 6).
(E and F) Intracellular cytokine expression of FACS-sorted CD56+CD127hi Lin
cells stimulated as indicated in the presence or absence of 1 mM PDTC (F, left)
or 100 nMCsA (F, right) is shown as mean percentage ± SEM (nR 3). See also
Figures S2 and S3.
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1228 Immunity 38, 1223–1235, June 27, 2013 ª2013 Elsevier Inc.when used alone. Only combination of IL-1 with IL-23, and to a
less extent with IL-7, was able to induce IL-22 expression in
RORgt+ ILCs. IL-1+IL-7+IL-23 stimulation resulted in the highest
IL-22 production (Figures 3C and 3D). In addition to IL-22,
IL-1+IL-7+IL-23 stimulation induced significant GM-CSF pro-
duction, while only very low TNF and IL-2 could be observed
(Figure 3E). Similar data could also be observed by measuring
mRNA content and amounts of secreted cytokines at different
time points (Figure S2C). IL-1+IL-7+IL-23 stimulation induced a
similar cytokine profile in CD56+ and CD56 RORgt+ ILCs,
despite the lower frequency of producers observed in the
CD56 compartment (data not shown). Conversely, only
NKp44+ cells produced IL-22 after IL-1+IL-7+IL-23 stimulation
(Figure 3F), similar to what we observed after PMA+Iono+IL-
23. Altogether, these data show that in contrast to NKp44 stim-
ulation, triggering of cytokine receptors induces preferential
expression of IL-22 but only very low TNF in RORgt+ ILCs.
Combined Engagement of NKp44 and Cytokine
Receptors in RORgt+ ILCs Results in Strong Synergistic
Effect
We next asked whether activating receptor and cytokine stimu-
lation may act synergistically to induce cytokine expression in
RORgt+ ILCs. Combination of NKp44 triggering with IL-1+IL-
7+IL-23 stimulation resulted in enhanced expression of all cyto-
kines analyzed (Figures 4A and 4B), at levels almost comparable
to PMA+Iono+IL-23 stimulation (Figure 4C). As expected, this
synergistic effect was confined to the NKp44+ cell compartment
(Figure 4D). Strong synergy of NKp44 triggering with IL-1+IL-
7+IL-23 stimulation could also be observed by measuring
mRNA content and amounts of secreted IL-22, GM-CSF, IL-2,
and TNF at different time points (Figure S2C). None of the stimuli
analyzed was able to induce considerable expression of IL-17A
(Figures S2D and S2E). Although IFN-g, IL-13, or IL-5 could
not be detected after any stimulation by intracellular staining
(Figure S2D), induction of IFN-g and IL-13 mRNA and minor
amounts of secreted protein could be detected especially after
aNKp44+IL-1+IL-7+IL-23 stimulation (Figure S2E). When we
dissected the effects of each single cytokine (IL-1, IL-7, and IL-
23) used in combination with NKp44 triggering, we observed
that aNKp44 stimulation synergized with IL-23 or IL-7 to induce
IL-22 expression but had only minor effects on TNF. Conversely,
combination of IL-1 and aNKp44 increased both IL-22 and TNF
expression (Figure 4E). Thus, NKp44 downstream signaling
Immunity
NKp44 Triggering Activates RORgt+ ILCsenhanced IL-22 transcription in the presence of cytokines. In
order to dissect the unique contribution of IL-1+IL-7+IL-23 and
aNKp44 on cytokine production, we stimulated RORgt+ ILCs in
the presence of different inhibitors. Whereas Cyclosporin A
(CsA), which preferentially blocks NFAT dephosphorylation,
selectively decreased cytokine production after aNKp44, but
not after IL-1+IL-7+IL-23 activation, the NF-kB inhibitor PDTC
could efficiently inhibit both stimulations (Figure 4F). In agree-
ment with previous data (Crellin et al., 2010), the pan Jak inhibitor
I selectively decreased cytokine expression induced by IL-1+IL-
7+IL-23, but not by aNKp44 stimulation (data not shown).
Altogether, we showed that the signaling synergy achieved by
IL-1+IL-7+IL-23 and NKp44 stimulation leads to optimal activa-
tion and cytokine production by RORgt+ ILCs.
NK Cell Activating Receptors Are Functional in Mouse
Splenic but Not in SI-Derived RORgtfm+ ILCs
Although NKp44 is not conserved between human and mouse
(Moretta et al., 2001), a fraction of mouse RORgt+ ILCs ex-
presses other NKR, such as NK1.1 and NKp46 (Luci et al.,
2009; Sanos et al., 2009; Satoh-Takayama et al., 2008). To test
whether NKR were functional in mouse RORgt+ ILCs, we took
advantage of Rorc-CreTg/Rosa26R-RFP fate-map (RORgtfm)
mice, in which all cells derived from RORgt+ ILC precursors
were marked by the RFP reporter. Thus, we analyzed whether
triggering of NK1.1 or NKp46 could lead to cytokine expression
in NKp46+ RORgtfm+ Lin cells, as compared to cNK cells
(NKp46+ RORgtfm Lin cells). NK1.1 expression was high in
spleen-derived, but lower or absent in SI-derived, RORgtfm+
ILCs (Figure S3A); moreover, IL-22 producing cells were en-
riched among SI-derived but not among splenic NKp46+
RORgtfm+ ILCs (Figure S3B), in line with other reports (Vonar-
bourg et al., 2010). Engagement of NK1.1 alone, or together
with IL-1+IL-23, induced IFN-g and TNF production in mouse
splenic NKp46+ RORgtfm+ ILCs, similar to cNK cells, but not in
NKp46+ RORgtfm+ ILCs nor in cNK cells derived from SI (Fig-
ure S3B). NKp46 cross-linking induced some IFN-g expression
in splenic cNK cells, but not in NKp46+ RORgtfm+ ILCs from
any compartment (data not shown). These data support the
concept that NKR are functional in mouse splenic, but not in
SI-derived, NKp46+ RORgtfm+ ILCs and that their engagement
results in IFN-g and TNF but not in IL-22 expression.
Engagement of NKp44 Ligands on Tumor Epithelial Cell
Lines Leads to Cytokine Expression in RORgt+ ILCs
NKp44may recognize pathogen-derived molecules, including IV
HA (Arnon et al., 2001), as well as undefined endogenous mole-
cules upregulated in transformed cells (Byrd et al., 2007).
Although H1N1 IV at different multiplicity of infection (MOI)
did not induce significant cytokine expression in RORgt+
ILCs (Figure S4A; data not shown), combination of IV with
IL-1+IL-7+IL-23 resulted in higher cytokine expression
compared to IL-1+IL-7+IL-23 alone (Figure S4A). However, IV-
mediated activation of RORgt+ ILCs did not appear to be
NKp44-dependent because it could not be inhibited by addition
of aNKp44-blocking mAb (Figure S4A). Therefore, we analyzed
whether IV-infected cells could represent a better target for
NKp44-recognition by RORgt+ ILCs. By infecting Madin-Darby
canine kidney (MDCK) cells, which are highly susceptible to IVinfection, we observed that IV-infected or noninfected MDCK
cells induced comparable cytokine expression in RORgt+ ILCs
(Figure S4B). Indeed, noninfected MDCK cells already displayed
a high binding to human NKp44-Fc (Figures 5A and 5B) andwere
able to selectively activate BW-NKp44 reporter cells (Figure 5C).
Stimulation of RORgt+ ILCs with MDCK cells with or without
IL-1+IL-7+IL-23 elicited cytokine expression similar to aNKp44
or aNKp44+IL-1+IL-7+IL-23, respectively, and could be
completely abolished by aNKp44 blocking mAb (Figures 5D
and 5E). Moreover, the human colorectal adenocarcinoma cell
line SW620, which displayed NKp44-Fc binding (Figures 5A
and 5B) and activated the BW-NKp44 reporter cell line, although
to amuch lower extent compared toMDCKcells (Figure 5C), was
able to induce cytokine expression in RORgt+ ILCs (Figures 5F
and 5G) in a partially NKp44-dependent manner (Figure 5F).
These data clearly indicate that RORgt+ ILCs can be activated
by the physiological interaction between NKp44 and its ligands
expressed on transformed epithelial cells, recapitulating what
we have observed by using aNKp44 or aNKp44+IL-1+IL-7+IL-
23 stimulation.
NKp44 Triggering Induces Selective Regulation of
Genes Related to Inflammatory Response
Selective engagement of NKp44 or cytokine receptors appeared
to promote different functions in RORgt+ ILCs. To confirm
this hypothesis, we performed transcriptome analysis of highly
purified CD56+ CD127hi ILCs ex vivo and after stimulation
with aNKp44, IL-1+IL-7+IL-23, or aNKp44+IL-1+IL-7+IL-23.
Compared to ex vivo, each stimulus induced significant regula-
tion of a number of genes, of which a consistent fraction was
coregulated under any of the tested conditions (Figure S5A),
thus showing that exclusive engagement of NKp44 is an acti-
vating stimulus with a genome-wide regulating effect, similar to
cytokine receptor stimulation. For instance, IL2RA (CD25) or
TNFRSF9 (CD137) transcripts were strongly upregulated after
all stimulations (Figure S5B). In line with our functional data,
each of the three stimulation conditions also resulted in a distinct
expression pattern of a number of genes, referred to as ‘‘noncor-
egulated’’ (Figure S5A; Figure 6A). By hierarchical clustering of
expression values of all noncoregulated genes, six main clusters
were identified (Figures 6A and 6B). Gene ontology (GO) analysis
was performed for each cluster with the aim to search for signif-
icant gene-sets enriched as compared to the entire genome (Fig-
ure 6A; Table S1). As shown in Figures 6A and 6B, Cluster 1
(green) and Cluster 5 (pink) included many genes downregulated
by either aNKp44 and/or IL-1+IL-7+IL-23 stimulation. Among
these clusters, genes related to negative regulation of biological
processes or regulation of phosphate metabolic processes were
overrepresented. Cluster 6 (yellow) included all noncoregulated
genes with high fold changes. This cluster assembled two
distinct set of genes, which were preferentially regulated either
by aNKp44, such as IL2, RCAN1, NR4A3 and PTGS2 (Cox-2),
or those whose expression was preferentially driven by cyto-
kines, such as IL22, SOCS2, SOCS3, SERPINA1, PRDM1
(Blimp-1), IFNG, and GZMB (granzyme B). Cluster 2 (blue)
included genes that were significantly upregulated only by cyto-
kines. In this cluster, we found an overrepresentation of genes
related to apoptosis. Moreover, IL26, STAT5A, CXCR5, and
SERPINB1 could be identified as relevant cytokine-regulatedImmunity 38, 1223–1235, June 27, 2013 ª2013 Elsevier Inc. 1229
Figure 5. Engagement of NKp44 by Tumor Epithelial Cell Lines Results in Cytokine Expression in RORgt+ ILCs
Ex vivo analysis of cytokine profile of human tonsil-derived FACS-sorted RORgt+ ILCs after stimulation with NKp44 ligand-positive tumor epithelial cell lines.
(A and B) Staining of MDCK and SW620 cell lines with NKp44-Fc (black solid line), Fc (black dotted line), or secondary anti-human IgG1 mAb (aIgG1) only (gray
histogram) is shownasone representative histogram (A) or asMFI ratioofNKp44-Fc/aIgG1 (triangles) or of Fc/aIgG1 (circles) fromsix independent experiments (B).
(C) BW or BW-NKp44 reporter cells were activated with irradiated MDCK (left) or SW620 (right) cells for 24 hr, and expression of murine IL-2 was measured by
ELISA. Mean absorbance (O.D. 450 nm) of duplicates from one representative experiment out of three is shown.
(D–G) FACS-sorted CD56+ CD127hi Lin cells were stimulated as indicated. Intracellular expression of the indicated cytokines was determined by FC, and one
representative experiment (D and G) and mean ± SEM (n = 6) (E) (nR 4) (F) are shown. See also Figure S4.
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Figure 6. NKp44 Triggering Induces Selec-
tive Regulation of Genes Related to Inflam-
matory Response
Transcriptome analysis of human tonsil-derived
FACS-sorted CD56+ CD127hi Lin ILCs.
(A) Heatmap of differentially regulated genes in at
least one of the three indicated stimuli compared
to ex vivo. Plotted are z values of fold changes for
three independent experiments. The color bar (left)
indicates six clusters determined by hierarchical
clustering (Ward’s Method) on scaled expression
values. Clusters were analyzed for GO enrichment
and representative terms are depicted aside.
(B) Scatterplot of fold changes induced by stimu-
lation with aNKp44 (y axis) and IL-1+IL-7+IL-23
(x axis) of all significantly regulated genes (in
relation to ex vivo). Black line indicates direction of
maximal variation of the fold change data, which
was determined by principal component analysis.
Gray dots represent genes showing largely
correlated fold changes among the three stimu-
lation conditions. Genes deviating from the axis of
maximal variation are differentially regulated be-
tween the two stimulation conditions aNKp44 and
IL-1+IL-7+IL-23. Colored dots represent all non-
coregulated genes between all three stimulation
conditions, as described in (A). Colors designate
their cluster membership. Selected genes of each
cluster have been labeled. See also Figure S5 and
Table S1.
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NKp44 Triggering Activates RORgt+ ILCsgenes. Clusters 3 (violet) and 4 (orange) mostly included genes
whose expression was preferentially driven by aNKp44 stimula-
tion. These clusters were enriched in genes related to inflamma-
tory response, response to wounding, I-kB/NF-kB cascade, and
cell migration, thus suggesting that aNKp44 stimulation triggers
a coordinated proinflammatory program. Among genes prefer-
entially regulated by NKp44 engagement, we could identify
TNF, TNFSF11 (RANKL), TNFSF14 (LIGHT), CCL20, CCL4,
XCL1, NR4A1, NR4A2, or THBS1 (thrombospondin). Most of
the genes modulated by aNKp44+IL-1+IL-7+IL-23 stimulation
were also found among the genes regulated by either aNKp44
or IL-1+IL-7+IL-23 stimulation (Figure S5C). Strong synergyImmunity 38, 1223–123occurred in selected gene transcription
(e.g., IL2, IL8, IL22), when aNKp44+IL-
1+IL-7+IL-23 stimulation was compared
to aNKp44 or IL-1+IL-7+IL-23 alone
(Figure S5C). Relevant gene signatures
were confirmed by qPCR (Figure S5B).
Some genes, such as IL23A (IL-23p19)
were significantly regulated only by
aNKp44+IL-1+IL-7+IL-23 stimulation, as
measured by mRNA (Figure S5B), as
well as by intracellular staining (Fig-
ure S5D). Conversely, IL-12/IL-23p40
protein (Figure S5D) and mRNA (data
not shown) were undetectable. From
this global analysis, it becomes evident
that RORgt+ ILC stimulation via NKp44
elicits an overlapping and distinct gene
signature compared to cytokines, espe-cially by inducing genes related to inflammatory response,
response to wounding, I-kB/NF-kB cascade, and cell migration.
Stimulus-dependent signatures induced in RORgt+ ILCs may
impact the cross-talk with epithelial cells, which express the
IL-22R. When activated with IL-1+IL-7+IL-23, but not with
aNKp44 alone, RORgt+ ILCs induced in the intestinal epithelial
cell (IEC) line HT-29 high mRNA expression of IL10 and of
regenerating islet-derived protein 3-alpha (REG3A), as well
as b-defensin4 (DEFB4A). Expression of all three genes could
be further enhanced in HT-29 by coculturing them together
with RORgt+ ILCs activated with aNKp44+IL-1+IL-7+IL-23
(Figure S5E). Similar data were obtained when HT-29 were5, June 27, 2013 ª2013 Elsevier Inc. 1231
Figure 7. Characterization and NKp44
Responsiveness of Colon LP Derived
RORgt+ ILCs
Phenotype and cytokine profile of RORgt+ ILCs
derived from human colon LP isolated from CRC
or IBD patients.
(A) Gating and sorting strategy to define CD127hi
Lin CD45+ cells in colon LP from CRC patients
(left). RORC and AHR transcripts were determined
by qPCR in FACS-sorted CD56+/ NKp46lo/neg
CD127hi Lin CD45+ cells (RORgt+ ILCs) and
CD56+ NKp46hi CD127 CD3 CD14 CD19
CD45+cells (cNK), asdescribed in Figure 1A (n=3).
(B) Expression of the indicated markers was
analyzed by FC in MNC from colon LP of CRC
patients after gating on CD56+ (red line) and
CD56 (blue line) CD127hi Lin CD45+ ILCs. One
representative experiment out of six is shown.
(C) FACS-sorted CD127hi Lin CD45+ ILCs
derived from colon LP of CRC patients were
stimulated for 6 hr with PMA+Iono+IL-23. Intra-
cellular cytokine expression detected by FC is
shown as one representative experiment (n = 3).
(D) NKp44 expression on MNC from macroscop-
ically noninflamed (NI) or inflamed (I) colon LP
samples from the same IBD patient or from non-
affected colon LP isolated from CRC patients was
determined by FC, after gating on CD56+ CD127hi
Lin CD45+. Mean percentage ± SEM of NKp44+
cells (CRC n = 4; IBD n = 6) (left) and one repre-
sentative experiment (right) are shown.
(E and F) FACS-sorted CD127hi Lin CD45+ cells
derived from colon LP of CRC patients were
stimulated with the specified stimuli and intracel-
lular expression of the indicated cytokines was
measured by FC. One representative experiment
(E) and mean percentage ± SEM of IL-22+ cells (F)
are shown (n = 3).
(G and H) mRNA transcripts of the specified genes
were analyzed by qPCR after stimulation of FACS-
sorted CD127hi Lin CD45+ cells derived from
colon LP of CRC patients. Data were normalized
to GAPDH and shown as mean fold change ±
SEM relative to unstimulated cells (n = 3).
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vated via the same stimuli (data not shown). These data support
the concept that RORgt+ ILCs might exert different effects on
IECs depending on the present stimulus and that RORgt+ ILC
activation with aNKp44+IL-1+IL-7+IL-23 promotes a strong
response in IECs.1232 Immunity 38, 1223–1235, June 27, 2013 ª2013 Elsevier Inc.Characterization and NKp44
Responsiveness of Colon-Derived
RORgt+ ILCs
RORgt+ ILCs have been described in
human gut lamina propria (LP) (Cella
et al., 2009; Geremia et al., 2011;
Takayama et al., 2010). Indeed, a consis-
tent population of CD127hi Lin CD45+
cells could be isolated from macroscopi-
cally inflamed or noninflamed colon
mucosa derived from IBD patients, as
well as from nonaffected colon of patientsundergoing colectomy for colorectal cancer (CRC) (Figure 7A).
Similar to tonsil-derived RORgt+ ILCs, colon LP CD127hi Lin
CD45+ cells displayed low expression of NKp46 and were
enriched inRORC andAHR transcripts (Figure 7A). No difference
in CD117, IL-1R1, or CD161 expression could be detected
among colon LP RORgt+ ILCs dissected according to CD56
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NKp44 Triggering Activates RORgt+ ILCs(Figure 7B). PMA+Iono+IL-23 stimulation resulted in numerous
cells producing IL-22, GM-CSF, IL-2, and TNF, whereas only a
few cells expressed IFN-g or IL-17A (Figure 7C). NKp44 was pre-
sent on the surface of a consistent fraction of colon LP RORgt+
ILCs, and its expression was comparable between noninflamed
colon of IBD patients and nonaffected colon of CRC control
patients. Notably, NKp44 expression among RORgt+ ILCs was
significantly lower in inflamed compared to noninflamed colon
LP samples from the same IBD patients (Figure 7D). Stimulation
of colon LP RORgt+ ILCs with IL-1+IL-7+IL-23 led to strong
induction of IL-22 but only to low TNF expression. NKp44
engagement could clearly synergize with cytokine stimulation
to enhance IL-22 expression (Figures 7E–7G), although only
very few cells were positive for intracellular TNF (Figure 7E). In
order to confirm the efficacy of NKp44 triggering in colon LP
RORgt+ ILCs, mRNA expression of TNF as well as CCL20 and
NR4A2, which were all regulated by NKp44 engagement in tonsil
RORgt+ ILCs (Figures 6B; Figure S5B), were analyzed. In linewith
our tonsil data, mRNA of all three genes was selectively induced
after NKp44 triggering, thus further corroborating its functionality
in colon LP RORgt+ ILCs (Figure 7H). Altogether, these data
show that colon LP RORgt+ ILCs represent a population strongly
enriched in RORgt+ NKp44+ IL-22-producing cells, which is
responsive to both IL-1+IL-7+IL-23 and NKp44 stimulation,
similar to their tonsil counterpart.
DISCUSSION
Themechanisms underlying the nature of the dual role of RORgt+
ILCs in regulation of inflammatory diseases are still poorly
understood. RORgt+ ILCs might include distinct cell subsets
characterized by different cytokine production and functional
properties. Our analysis of human tonsil CD127hi ILC subsets
dissected according to both CD56 and NKp44 revealed that,
although all subsets analyzed could be collectively referred to
as RORgt+ ILCs, expression of IL-22 was strictly confined to
the NKp44+ fraction, in line with a recent report (Hoorweg
et al., 2012). Conversely, expression of TNF was not confined
to a particular subset but rather represented a common feature
of all RORgt+ ILC subsets.
One alternative explanation for the double nature of RORgt+
ILCs could be that these cells display distinct effector functions
depending on their context of activation; for instance, after
engagement of cytokine receptors or of innate sensors. This
concept is supported by previous evidence showing that activa-
tion of RORgt+ ILCs with TLR2 agonists together with IL-23 in-
duces IL-22 production, whereas combination of TLR2 agonists
with IL-2 results in IL-22 and in IL-13 and IL-5 expression (Crellin
et al., 2010). In line with this idea, we show that cytokine or
aNKp44 stimulation could trigger partially distinct signatures in
RORgt+ ILCs. Importantly, activation via cytokine receptors
induced a preferential upregulation of IL-22, which mainly drives
tissue repair andmucosal homeostasis (Ouyang et al., 2011), but
resulted in only low TNF expression. Besides IL-22, cytokine
stimulation of RORgt+ ILCs upregulated the expression of
alpha-1 antitrypsin (SERPINA1) and leukocyte elastase inhibitor
(SERPINB1), which are involved in tissue protection and are
also induced in IECs by IL-22 stimulation (Cella et al., 2009).
Conversely, NKp44 triggering induced TNF expression in theframe of a coordinated proinflammatory program. Thus, our
data imply that NKp44+ RORgt+ ILCs can switch between
IL-22 and TNF production depending on the triggering stimulus.
Little evidence has been provided that RORgt+ ILCs can sense
and react to the environment directly, independent of proinflam-
matory cytokines. In humans, it was shown that RORgt+ ILCs
could be activated by TLR2 in combination with IL-23 or IL-2
(Crellin et al., 2010). Our observation that NKp44 triggering alone
elicited TNF production in RORgt+ ILCs strongly supports the
idea that RORgt+ ILCs are endowed with pattern recognition re-
ceptors directly sensing the environment, regardless of cytokine
stimulation. Although HA of H1N1 IV has been previously identi-
fied as a potential ligand of NKp44 (Arnon et al., 2001), IV
infection of RORgt+ ILCs did not lead to consistent cytokine
expression, in contrast to what has been shown for cNK cells
(Jost et al., 2011). Moreover, cytokine expression induced after
RORgt+ ILC stimulation with IV+IL-1+IL-7+IL-23 did not appear
to be NKp44-dependent. Because a critical point for the
NKp44 (or NKp46) interaction with HA is the glycosylation of
the receptor, we cannot exclude that NKp44 might be differently
glycosylated in RORgt+ ILCs and NK cells. Further investigation
should validate this hypothesis. However, we could clearly show
that engagement of undefined NKp44 ligands on transformed
epithelial cell lines induced NKp44-dependent cytokine ex-
pression in RORgt+ ILCs. Our data suggest that high-affinity
conserved NKp44-ligands, able to activate RORgt+ ILCs, might
be also expressed on the canine MDCK cell line. Because
NKp44 is also expressed in canine NK cells (Huang et al.,
2008), NKp44 ligands might have coevolved together with their
receptor as shown for B7H6 and NKp30 (Flajnik et al., 2012).
Nonetheless, the nature of the NKp44 ligands eliciting inflamma-
tory signatures in RORgt+ ILCs remains to be explored, and only
their identification will comprehensively enlighten the physiolog-
ical relevance of NKp44 engagement in RORgt+ ILCs. Until then,
we can only speculate that NKp44 recognition of ligands ex-
pressed by microorganisms or IECs could participate in fighting
selected pathogens, restraining gut microflora, or even regu-
lating IEC homeostasis at steady state or during inflammation.
Because TNF represents a major proinflammatory cytokine
involved in the pathogenesis of several chronic autoimmune
diseases, the in vivo role of RORgt+ ILC-derived TNF certainly
deserves further investigation. Besides TNF, other proinflamma-
tory cytokines such as IFN-g or IL-17A are shown to be produced
by RORgt+ ILCs (Cella et al., 2010; Geremia et al., 2011).
Although only low expression of IFN-g protein could be
detected, IFNG transcripts were induced after IL-1+IL-7+IL-23
stimulation, suggesting that IFN-gmight undergo posttranscrip-
tional regulation in stimulated RORgt+ ILCs. A discrepancy
between protein and mRNA content for GM-CSF and TNF could
also be observed. Interestingly, MAP-kinase-activated protein
kinase (MK2), which modulates the translation and stability of
TNF mRNA (Kotlyarov et al., 1999), was upregulated in stimu-
lated tonsil RORgt+ ILCs (data not shown), thus likely contrib-
uting to modulate TNF expression in RORgt+ ILCs.
Finally, in line with previous data (Luci et al., 2009; Satoh-
Takayama et al., 2009), we have shown that NKR triggering did
not induce cytokine expression in mouse SI-derived NKp46+
RORgtfm+ ILCs. Conversely, mouse splenic NKp46+ RORgtfm+
ILCs produced IFN-g and TNF in response to NK1.1 stimulation,Immunity 38, 1223–1235, June 27, 2013 ª2013 Elsevier Inc. 1233
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matory cytokines after NKR engagement is partially conserved.
However, because mouse splenic NKp46+ RORgtfm+ ILCs are
not proficient IL-22 producers, mouse NKR might not play any
role in IL-22 induction.
Altogether, our data clearly demonstrate that RORgt+ ILCs can
directly sense the environment by engagement of NKp44 and
that selective triggering of activating or cytokine receptors con-
tributes to determine the cytokine profile and functional proper-
ties of NKp44+ RORgt+ ILCs. Hence, NKp44 might represent an
interesting therapeutic target to modulate proinflammatory
versus protective features of RORgt+ ILCs during inflammatory
diseases.
EXPERIMENTAL PROCEDURES
Cell Isolation and Flow Cytometry
Cell populations from human tonsils were isolated from patients undergoing
tonsillectomy, as previously described (Ryon, 2001). Gut LP cells were isolated
from CRC or IBD patients undergoing colectomy, by using a modified version
of the protocol of Bull and Bookman (Bull and Bookman, 1977). Written
informed consent was obtained from all patients prior to sample acquisition
and experiments have been approved by the Ethics Committee of the Charite´
Medical University, Berlin (EA4/106/11 and EA1/107/10). RORgt+ ILCs were
enriched by using magnetic cell sorting (MACS): CD3+ T cells were first
depleted by using anti-CD3microbeads and CD127+ cells were then positively
selected by using CD127 microbead kit. Alternatively, CD56+ RORgt+ ILCs
were directly enriched by using anti-CD56 microbeads (all Miltenyi Biotec).
All MACS enriched cell fractions were subsequently FACS sorted to high purity
(above 95%) by using FACSAria II cell sorter (BD Biosciences), according to
markers indicated in the figure legends. Flow cytometric analysis was per-
formed by using BD FACSCanto II or Fortessa employing FACSDiva Software
(BD Biosciences), and data were analyzed by using FlowJo software (Tree
Star). Further details and list of antibodies used have been included in Supple-
mental Information. Isolation of murine cells is described in the Supplemental
Information. Experiments were approved and in accordance with local animal
care and use committees.
In Vitro Stimulation, Intracellular Staining, and ELISA/CBA
We cultured 20,000 cells of FACS-sorted human ILC subsets in RPMI contain-
ing 10% human AB serum (Lonza), 100 U/mL Penicillin, and 0.1 mg/ml
Streptomycin (PAA Laboratories). When indicated, PMA (20 ng/ml), Ionomycin
(1 mg/ml; both Sigma), IL-1, IL-7 (Miltenyi Biotec), and IL-23 (R&D Systems;
50 ng/ml each) were added. For activating receptor stimulation, 20 mg/ml of
biotinylated antibodies specific for NKp44 (2.29), NKp30 (AF29-4D12),
NKp46 (9E2), CD2 (LT2), CD161 (191B8), or NKG2D (BAT221) were conjugated
to anti-biotin MACSiBead particles (all Miltenyi Biotec) and used to stimulate
human RORgt+ ILCs at bead:cell ratio of 5:1. When indicated, cells were
incubated with 1 mM PDTC (Calbiochem), 100 nM CsA (Sigma), or 1 mM of
Jak inhibitor I (Millipore) at 37C for 1 hr prior to stimulation. For blockade
of NKp44 engagement, cells were incubated with anti-NKp44 (KS38, IgM) or
anti-CD56 (A6-220, IgM isotype control) mAb (10 mg/ml) at 4C for 1 hr prior
to stimulation. KS38 and A6-220 were kindly provided by S. Parolini, University
of Brescia, and A. Moretta, University of Genova, Italy, respectively.
Intracellular cytokine staining was performed either after 20 hr (human
tonsil), if not indicated differently, or 6 hr (human gut) of stimulation in the pres-
ence of Brefeldin A (10 mg/ml) (Sigma). Cells were fixed with 2% paraformalde-
hyde (Electron Microscopy Services) and stained intracellular in the presence
of 0.5% saponin (Sigma) in PBS. Activated NF-kB, STAT5, and STAT3 were
detected after 15 min stimulation by using Cytofix buffer and PermIII (all BD
Biosciences). Cytokines in cell culture supernatants of stimulated RORgt+
ILCs were determined by using Cytometric Bead Array (BD Biosciences)
with the exception of IL-22, whichwas detected by ELISA (Biolegend), accord-
ing to manufacturer’s instruction. Further details have been included in
Supplemental Information. Reagents and experimental procedures employing
murine cells are described in the Supplemental Information.1234 Immunity 38, 1223–1235, June 27, 2013 ª2013 Elsevier Inc.Activation of NKp44–CD3z Chimera (BW-NKp44)
Murine BW thymoma cells untransfected and BW-NKp44 stable transfectants
were a kind gift of O. Mandelboim (Hebrew University Hadassah Medical
School, Jerusalem, Israel). The experimental procedure is described in Sup-
plemental Information.
Quantitative RT-PCR (qPCR)
mRNA was isolated from cells by using NucleoSpin RNAII (Macherey Nagel).
cDNA was synthesized by using Reverse Transcription Reagents and assayed
by qPCR in duplicates by using a StepOne Plus real-time PCR system and
TaqMan Gene expression assays (all Applied Biosystems). A list of all TaqMan
Gene expression assays employed is included in Supplemental Information.
mRNA content was normalized to GAPDH expression. Mean relative gene
expression was determined by using the DDCT method.
Microarray Gene Expression Profiling
RORgt+ ILCs were stimulated for 3.5 hr and RNA was isolated by using
NucleoSpin RNAII. cDNA was synthesized from 100 ng total RNA (Ambion)
pooled from four or two donors. cRNA was synthesized using Enzo RNA
Transcript Labeling kit (Affymetrix). Three replicates of biotinylated cRNA
(15 mg) per group were fragmented and hybridized to 12 Affymetrix HG U133
plus 2.0 GeneChips by using standard Affymetrix protocols. The arrays were
scanned with an Affymetrix GeneChip Scanner 3000. Further details have
been included in Supplemental Information.
Statistical Analysis
Wilcoxon signed rank two-tailed test was employed for statistical analysis of
data sets consisting of at least six independent experiments (*p < 0.05, **p <
0.01, ***p < 0.001) by using GraphPad Prism (GraphPad Software).
ACCESSION NUMBERS
Raw data of resulting chips were uploaded to Gene Expression Omnibus
(GEO) database repository under the following series accession number:
GSE43409.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.immuni.2013.05.013.
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